Thursday, Jun 04, 2020 | Last Update : 11:31 AM IST

72nd Day Of Lockdown

Maharashtra74860323292587 Tamil Nadu2587214316208 Delhi236459542615 Gujarat18117122121122 Rajasthan96526744209 Uttar Pradesh88705257230 Madhya Pradesh82835003358 West Bengal61682410364 Karnataka4063151453 Andhra Pradesh3971246468 Bihar3945174123 Telangana3020155699 Jammu and Kashmir260194631 Odisha238814169 Haryana2356105521 Punjab2301200044 Kerala149565112 Assam14862854 Uttarakhand9592225 Jharkhand6612965 Chhatisgarh5481211 Tripura4231730 Himachal Pradesh3401186 Chandigarh2972144 Puducherry88300 Manipur83110 Goa73500 Nagaland5800 Arunachal Pradesh3710 Meghalaya33131 Mizoram1410 Sikkim200

Govt, CSIR pact on ayurveda research

THE ASIAN AGE. | RAHUL CHHABRA
Published : May 6, 2019, 3:18 am IST
Updated : May 6, 2019, 3:18 am IST

CSIR labs have already produced anti-diabetic drug BGR-34

The CSIR director said the MoU will also help in development of international standardised terminologies (disease-morbidity codes) in ayurveda, siddha and unani. (Representational image)
 The CSIR director said the MoU will also help in development of international standardised terminologies (disease-morbidity codes) in ayurveda, siddha and unani. (Representational image)

New Delhi: Auguring well for research in ayurveda and other traditional systems of medicine, the Union ministry of Ayush and the Council of Scientific and Industrial Research (CSIR) have joined hands to help integrate modern scientific methods with Indian’s centuries-old knowledge and promote herbal products.

An agreement for this purpose was recently signed by Union Ayush secretary Vaidya Rajesh Kotecha and CSIR director Shekhar C. Mande.

In the past, too, CSIR labs have undertaken research, along the Central Institute of Medicinal and Aromatic Plants (CIMAP) and the National Botanical Research Institute (NBRI), to jointly develop anti-diabetic herbal drug BGR-34. The scientifically validated poly-herbal ayurvedic blood glucose regulator BGR-34, marketed by marketed by Delhi-based AIMIL Pharmaceuticals, has been prepared from six medicinal plants. Mr Kotecha said that a combination of traditional healthcare and modern basic science has a huge potential for path-breaking research.

As per the latest MoU, the ministry and the CSIR will pursue R&D on ayush specific diagnostic tools and multi-ingredient herbal formulations, including their standardisation. Collaboration in preserving and protecting traditional knowledge related to the Indian systems of healthcare will also be strengthened, said a ministry statement.

Mr Mande said that enhancing the collaboration with the ministry through joint R&D efforts ranging from fundamental science to validation and, thereafter, product development will significantly help in the growth of the Indian contribution to the herbal drugs sector, not only nationally but also internationally.

He expressed confidence that the partnership with the ministry will help boost the prospects of Indian herbal products in quality-conscious domestic as well as global market.

The CSIR director said the MoU will also help in development of international standardised terminologies (disease-morbidity codes) in ayurveda, siddha and unani.

Tags: csir, ayurveda